Table 1.
Patient and surgical characteristics
| Characteristic | Yes (%) | ||
|---|---|---|---|
| Male | 22 (88) | ||
| Coronary artery disease | 14 (56) | ||
| Congestive heart failure | 0 (0) | ||
| Chronic obstructive pulmonary disease | 1 (4) | ||
| Obstructive sleep apnea | 8 (32) | ||
| Chronic kidney disease | 2 (8) | ||
| Acute kidney injury | 0 (0) | ||
| Cerebral vascular accident | 1 (4) | ||
| Diabetes miletus | 3 (12) | ||
| Liver disease | 0 (0) | ||
| Valvular disease | 14 (56) | ||
| Coronary artery bypass graft | 11 (44) | ||
| Aortic valve surgery | 11 (44) | ||
| Mitral valve surgery | 4 (16) | ||
|
| |||
| Mean | Standard Deviation | Range | |
|
| |||
| Age (years) | 55.56 | 11.89 | 31-76 |
| Body mass index (kg/m2) | 29.81 | 5.10 | 21.24-42.48 |
| Preoperative platelet count (×109/L) | 211.68 | 57.12 | 138-387 |
| Preoperative prothrombin time (s) | 14.89 | 5.50 | 12.00-36.60 |
| Preoperative partial thromboplastin time (s) | 35.32 | 20.25 | 12.9-105.60 |
| Preop creatinine (mg/dl) | 1.02 | 0.26 | 0.57-1.67 |
| Duration of cardiopulmonary bypass (min) | 131.04 | 39.17 | 55-220 |
| Duration of cross clamp (min) | 100.32 | 29.97 | 43-154 |
| Heparin dose (international units) | 29320 | 6381.74 | 15000-40000 |
| Protamine dose (mg) | 239.44 | 58.32 | 100-400 |
| Postoperative platelets (×109 L) | 143.8 | 40.07 | 82-243 |
| Postoperative prothrombin time (s) | 16.86 | 1.26 | 14.6-19.2 |
| Postoperative partial thromboplastin time (s) | 31.90 | 4.66 | 25.5-46.2 |
| Postoperative creatinine (mg/dl) | 0.92 | 0.22 | 0.43-1.28 |
| Postoperative fibrinogen (mg/dl) | 218.13 | 52.01 | 127-338 |